SCHEMBL17599358

SCHEMBL17599358

Cc1cc(C)c(C)c(S(=O)(=O)Nc2ccc(-c3ccc(F)c(C(=O)O)c3)c3ccccc23)c1C

nearest known ligand 0.58

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.58
▸ HSD17B10 Q99714 2/20 0.58
▸ KDM4E B2RXH2 1/20 0.58
▸ MEN1 O00255 1/20 0.58
▸ HPGD P15428 1/20 0.58
▸ CRHBP P24387 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ CRHR2 Q13324 1/20 0.58
▸ MCL1 Q07820 6/20 0.53
▸ FABP4 P15090 7/20 0.50
▸ FABP5 Q01469 5/20 0.50
▸ KEAP1 Q14145 3/20 0.48
▸ NFE2L2 Q16236 1/20 0.48
▸ ACLY P53396 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599324 0.90 MEN1 (0.47) ALDH1A1HSD17B10KDM4EMEN1HPGD
SCHEMBL17599423 0.84 ALDH1A1 (0.56) ALDH1A1HSD17B10KDM4EMEN1HPGD
SCHEMBL17599370 0.82 ALDH1A1 (0.53) ALDH1A1HSD17B10KDM4EMEN1HPGD
SCHEMBL17599372 0.82 ALDH1A1 (0.62) ALDH1A1HSD17B10KDM4EMEN1HPGD
SCHEMBL17599329 0.82 KMT2A (0.55) ALDH1A1HSD17B10KDM4EMEN1HPGD
SCHEMBL17613344 0.79 FABP4 (0.41) ALDH1A1HSD17B10MCL1FABP4FABP5
SCHEMBL17599352 0.79 ALDH1A1 (0.63) ALDH1A1HSD17B10KDM4EMEN1HPGD
SCHEMBL17599470 0.74 MEN1 (0.46) ALDH1A1HSD17B10KDM4EMEN1HPGD
SCHEMBL17599346 0.73 CDC25B (0.45) ALDH1A1HSD17B10KDM4EMEN1HPGD
SCHEMBL17599380 0.73 MEN1 (0.44) ALDH1A1HSD17B10KDM4EMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback